Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study.

Authors: Mease LE,Coldren RL,Musila LA,Prosser T,Ogolla F,Ofula VO,Schoepp RJ,Rossi CA,Adungo N,
Address: Division of Preventive Medicine, Walter Reed Army Institute of Research, 503 Robert Grant Ave,, Silver Spring, MD 20910, USA. luke.mease@us.army.mil
Journal: Virol J.


Publication: 2011 Jul 27;8:371. doi: 10.1186/1743-422X-8-371.
Free Text: Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study.

abstract

BACKGROUND:

Arthorpod-borne viruses (arboviruses) cause wide-spread morbidity in sub-Saharan Africa, but little research has documented the burden and distribution of these pathogens.

METHODS:

Using a population-based, cross-sectional study design, we administered a detailed questionnaire and used ELISA to test the blood of 1,141 healthy Kenyan adults from three districts for the presence of anti-viral Immunoglobulin G (IgG) antibodies to the following viruses: dengue (DENV), West Nile (WNV), yellow fever (YFV), Chikungunya (CHIKV), and Rift Valley fever (RVFV).

RESULTS:

Of these, 14.4% were positive for DENV, 9.5% were WNV positive, 9.2% were YFV positive, 34.0% were positive for CHIKV and 0.7% were RVFV positive. In total, 46.6% had antibodies to at least one of these arboviruses.

CONCLUSIONS:

For all arboviruses, district of residence was strongly associated with seropositivity. Seroprevalence to YFV, DENV and WNV increased with age, while there was no correlation between age and seropositivity for CHIKV, suggesting that much of the seropositivity to CHIKV is due to sporadic epidemics. Paradoxically, literacy was associated with increased seropositivity of CHIKV and DENV.



Related Articles
Review Present and future arboviral threats.
Antiviral Res. 2010
Review Present and future arboviral threats.
Weaver SC, Reisen WK. Antiviral Res. 2010 Feb; 85(2):328-45. Epub 2009 Oct 24.
Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.
Am J Trop Med Hyg. 2008
Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.
Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, Bedno S, Burke H, Dumilla AM, Konde J, et al. Am J Trop Med Hyg. 2008 Feb; 78(2):333-7.
Serologic evidence of arboviral infections among humans in Kenya.
Am J Trop Med Hyg. 2011
Serologic evidence of arboviral infections among humans in Kenya.
Sutherland LJ, Cash AA, Huang YJ, Sang RC, Malhotra I, Moormann AM, King CL, Weaver SC, King CH, LaBeaud AD. Am J Trop Med Hyg. 2011 Jul; 85(1):158-61.
Postepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort study.
PLoS Negl Trop Dis. 2011
Postepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort study.
LaBeaud AD, Muiruri S, Sutherland LJ, Dahir S, Gildengorin G, Morrill J, Muchiri EM, Peters CJ, King CH. PLoS Negl Trop Dis. 2011 Aug; 5(8):e1265. Epub 2011 Aug 16.
Review The global emergence/resurgence of arboviral diseases as public health problems.
Arch Med Res. 2002
Review The global emergence/resurgence of arboviral diseases as public health problems.
Gubler DJ. Arch Med Res. 2002 Jul-Aug; 33(4):330-42.
Refining the global spatial limits of dengue virus transmission by evidence-based consensus.
PLoS Negl Trop Dis. 2012
Refining the global spatial limits of dengue virus transmission by evidence-based consensus.
Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI. PLoS Negl Trop Dis. 2012; 6(8):e1760. Epub 2012 Aug 7.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.